Both in Pharmaceuticals
Wave Life Sciences vs Design Therapeutics
Over the past year WVE returned −57.6% and DSGN returned +55.0%; their daily moves had a correlation of 0.13.
WVE −57.6% DSGN +55.0%Growth of $1, one year, split-adjusted
| Metric | WVE | DSGN |
|---|---|---|
| Price | $3.52 | $10.15 |
| Market cap | $694.2M | $635.2M |
| Today | −1.95% | −4.96% |
| 1 month | −6.9% | −17.7% |
| 6 months | −52.9% | −22.9% |
| Year to date | −79.3% | +8.2% |
| 1 year | −57.6% | +55.4% |
| Revenue growth (YoY) | +72.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −470.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.8× | — |
| Net cash | $430.7M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 55.4% |
| Short % of float | 17.0% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).